- Home
- AUPH vs GES Comparison
AUPH vs GES Comparison
Compare AUPH & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | GES |
|---|---|---|
| Founded | 1993 | 1981 |
| Country | Canada | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 872.4M |
| IPO Year | 1999 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AUPH | GES |
|---|---|---|
| Price | $14.64 | $16.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $17.25 | $16.75 |
| AVG Volume (30 Days) | ★ 939.1K | 811.4K |
| Earning Date | 02-26-2026 | 11-25-2025 |
| Dividend Yield | N/A | ★ 5.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.55 | ★ 1.07 |
| Revenue | $265,808,000.00 | ★ $3,144,417,000.00 |
| Revenue This Year | $21.76 | $8.97 |
| Revenue Next Year | $16.45 | $4.07 |
| P/E Ratio | $27.01 | ★ $15.68 |
| Revenue Growth | ★ 20.62 | 6.44 |
| 52 Week Low | $6.55 | $8.48 |
| 52 Week High | $16.54 | $17.15 |
Technical Indicators
Market Signals| Indicator | AUPH | GES |
|---|---|---|
| Relative Strength Index (RSI) | 38.52 | 52.05 |
| Support Level | $14.36 | $16.82 |
| Resistance Level | $15.19 | $16.88 |
| Average True Range (ATR) | 0.49 | 0.05 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 15.31 | 62.50 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.